Cookies Policy
What is a cookie?
When we provide services, we want to make them easy, useful and reliable. Where services are delivered on the internet, this sometimes involves placing small amounts of information on your device, for example, computer or mobile phone. These include small files known as cookies. They cannot be used to identify you personally.
These pieces of information are used to improve services for you through, for example:
- enabling a service to recognise your device so you don't have to give the same information several times during one task
- recognising that you may already have given a username and password so you don't need to do it for every web page requested
- measuring how many people are using services, so they can be made easier to use and there's enough capacity to ensure they are fast analysing anonymised data to help us understand how people interact with government services so we can make them better
Which cookies do we use?
By understanding how people use the website, we can improve the information provided. We use the following cookies on our website. Most of these are set by third-party suppliers.
|
Cookie name |
Provider |
Type |
Expiry |
Purpose |
|---|---|---|---|---|
|
has_js |
nbt.nhs.uk |
HTTP |
Session |
Registers whether or not the user has activated JavaScript in the browser. |
|
_ga |
nbt.nhs.uk |
HTTP |
2 years |
Registers a unique ID that is used to generate statistical data on how the visitor uses the web site. |
|
_gat |
Nbt.nhs.uk |
HTTP |
Session |
Used by Google Analytics to throttle request rate. |
|
_gid |
Nbt.nhs.uk |
HTTP |
Session |
Registers a unique ID that is used to generate statistical data on how the visitor uses the web site. |
| mmc-cookie-consent | nbt.nhs.uk | HTTP | Session | Stores the user's cookie consent choice. |
|
Collect |
Google-analytics.com |
Pixel |
Session |
Used to send data to Google Analytics about the visitor's device and behaviour. Tracks the visitor across devices and marketing channels. |
|
PREF |
Youtube.com |
HTTP |
8 months |
Registers a unique ID that is used by Google to keep statistics of how the visitor uses You Tube videos across different web sites. |
|
VISITOR_INFO1_LIVE |
Youtube.com |
HTTP |
179 days |
Tries to estimate the users' bandwidth on pages with integrated YouTube videos. |
|
YSC |
Youtube.com |
HTTP |
Session |
Registers a unique ID to keep statistics of what videos from YouTube the user has seen. |
How can I control and delete cookies?
We will not use cookies to collect personal identifiable information about you.
However, if you wish to restrict or block the cookies which are set by our websites, or indeed any other website, you can do this through your browser settings. The ‘Help’ function within your browser should tell you how.
Alternatively, you may wish to visit www.aboutcookies.org which contains comprehensive information on how to do this on a wide variety of browsers. You will also find details on how to delete cookies from your machine as well as more general information about cookies.
Please be aware that restricting cookies may impact on the functionality of our website.
If you wish to view your cookie code, just click on a cookie to open it. You'll see a short string of text and numbers. The numbers are your identification card, which can only be seen by the server that gave you the cookie.
For information on how to do this on the browser of your mobile phone you will need to refer to your handset manual.
To opt-out of third-parties collecting any data regarding your interaction on our website, please refer to their websites for further information.
For further queries please email NBTCommunications@nbt.nhs.uk
Equality Delivery System
The NHS Equality Delivery System (EDS) is designed to help NHS organisations improve equality performance and embed equality into mainstream NHS business so that we can provide a better service that meets the requirements of people from diverse communities. North Bristol NHS Trust has worked through the framework to provide evidence to support our grading.
This was used to devise our Equality Objectives.
NBT aims to work in partnership with a wide range of local communities including marginalised and seldom-heard groups.
The Trust works closely with other NHS partners to deliver the EDS and engages with them to gather feedback from communities on the quality of our service delivery. This offers local stakeholders the opportunity to be fully involved in the process where important decisions are made about the planning, developing, commissioning, management and delivery of health services.
We also engage with staff to ensure they can help to plan, develop and manage working environments and activities that aim to improve their working lives.
Equality & Diversity
At North Bristol NHS Trust, we respect and value the diversity of our workforce, patients, service users, relatives, carers and visitors and are committed to:
- Serving our community in a way that is appropriate, accessible and responsive
- Making best use of the range of talent and experience available within our workforce and potential workforce
- Ensuring that our legal obligations are fulfilled
It is recognised that individual and institutional discrimination obstruct the fundamental aims and objectives of NBT as a public service provider.
We are mainstreaming equality into all our functions and policies with the intention of achieving a fully inclusive organisation. A zero tolerance policy towards harassment and bullying towards anyone on Trust premises is endorsed throughout the organisation.
The Trust is committed to taking positive action for disabled people and has been awarded the Two Tick disability symbol. We have also signed up to the Mindful Employer charter as we are positive about mental health and take steps to increase awareness of mental health at work. For more details about the charter visit www.mindfulemployer.net
Equality & Diversity Committee
The Equality and Diversity Committee is the main forum through which progress on equality, diversity and human rights is managed. It’s principle function is to ensure that the Trust Board is informed of its legal duties and to promote the mainstreaming of equalities in all of our activities for patients, visitors and staff. It provides direction on equality for the Trust including strategies to develop consultation and involvement.
The Equality and Diversity Committee is made up of members of senior staff, including those from equality groups and others from the community.
The Brain Box Fund
Donations are welcome for supporting research into brain tumours at Bristol. Current work in progress is looking at a particular molecular marker in malignant glial tumours in collaboration with the University of Bristol.
Please make cheques payable to 'The Brain Box Fund' and send it to:
'The Brain Box Fund'
c/o Jackie Scholes
Secretary to Mr V Iyer
Consultant Neurosurgeon
Southmead Hosptial
Westbury-on-Trym
Bristol, BS10 5NB.
Please contact Jackie Scholes if you require any further information.
BNOG Referral Help
To contact the MDT co-ordinator for all MDTs with any queries about patient referrals please ring Rachael Eldridge on 0117 4140531. Working hours are Monday to Friday 8.00am to 4:00pm. Please leave a message on the answer machine outside these hours, or if the issue is more urgent please contact the On-call Neurosurgical Registrar at Southmead Hospital through the Switchboard (0117 950 5050) and ask for extension 45726.
If there are any questions about specific disease conditions please refer to 'Meet the Team' Page to contact the appropriate specialist.
Treatment
Most of the information in this section pertains to intrinsic brain tumours such as Gliomas or metastases. For tumours such as meningiomas, acoustic neuromas and pituitary adenomas even though general principles of intracranial surgery apply, there will be specific issues pertaining to these tumours that will be detailed in the relevant sections. The first treatment for most brain tumours is either surgery to remove the tumour or a biopsy to obtain a small sample of tumour. The tumour tissue that is removed is used to determine the exact type of tumour. Find out more about surgery for suspected brain tumours here:
There are several types of equipment available to the neurosurgeon. Specialised equipment is used to accurately localise the tumour within the brain and to track the margins of normal and abnormal tissue. This is similar to a satnav while driving, where the position of your car is shown relative to the street map. This is known as Image guidance (or Neuro navigation) and it increases safety and accuracy of tumour resection. Ultrasonic aspirators can be used to break up and suck out the tumour. High-powered microscopes may be used to better see the tumour tissue and surrounding nerves and blood vessels. Because the tentacle-like cells of an astrocytoma grow into the surrounding tissue, complete resection of these tumours is difficult to achieve without also removing normal brain tissue. Therefore a compromise has to be made between removing tumour tissue and preserving normal tissue. At surgery visibly abnormal looking tissue is removed. If the image guidance equipment shows that what looks visibly like normal brain could also represent abnormal tumour, then that area is also removed if it is felt by the surgeon that it will not lead to any compromise in neurological function. If the abnormal looking area on image guidance is an area that is vital for important bodily functions, then it is left intact, and treated non surgically depending on the type of tumour. Partial removal can help decrease symptoms and confirm the type of tumour.
BNOG Team
Consultant Neurosurgeon and Lead Oncology Surgeon
Mr Venkat Iyer MBBS, MS, MD, FRCS (Ed), FRCS (Glas), FRCS (Neurosurgery) PGCert (ME)
Mr Iyer specialises in treating patients with Intrinsic (within the brain substance) Primary and Secondary tumours in all parts of the brain and leads the delivery of Oncology services for Brain tumour patients. He operates on the majority of intrinsic brain tumours that are referred and is Chairman of the multi disciplinary team (MDT) that meets every week to discuss patients with brain tumours. His workload involves performing awake craniotomies on patients with both low grade and high grade gliomas, and in addition uses intraoperative electrophysiology for accurate localisation. He works very closely with the Cancer specialists (delivering radiotherapy and chemotherapy) at Bristol, Bath and Gloucester, and is part of the team involved in delivering Stereotactic Radiotherapy at Bristol (similar to ‘Gamma Knife’) to selected Brain tumours. He is also actively involved in research into Brain Cancer in collaboration with the University of Bristol and is looking at a unique cancer promoting enzyme called GSK3. He is a key fund holder for the ‘The Brain Box Fund' which is a charitable account funded by voluntary donations for supporting Research into Brain Cancer. email: venkat.iyer@nbt.nhs.uk
Medical Secretary (NHS): 0117 4146704
Consultant Neurosurgeon
Mr George Malcolm MBBS, BSc, FRCS (Neurosurgery)
Mr George Malcolm has been a Consultant Neurosurgeon in Bristol since 1999. He completed his training by spending a year as the Paediatric Neurological Surgery Fellow in the University of Tennessee at Memphis. During this year Mr Malcolm had the great privilege of working with Dr. Robert. A. Sanford who has an established reputation in the management of CNS tumours. It was while with Dr. Sanford that Mr Malcolm developed his interest in Neuro-oncology. His clinical practice is currently divided between Neurooncology and complex cervical surgery.
Contact: George.malcolm@nbt.nhs.uk
Consultant Neurosurgeon
Mr Richard Nelson
Mr Nelson was appointed as a Consultant Neurosurgeon at Frenchay Hospital, Bristol, in 1990. He trained in Cambridge, Oxford, London and Southampton. He has a special interest in the management of tumours of the skull base, in particular pituitary tumours and acoustic neuromas. He has been the lead surgeon for the Bristol Pituitary Service for the last 10 years and has undertaken over 500 transphenoidal operations. He works closely with colleagues in Endocrinology and Ophthalmology through regional clinics based in Bristol, Gloucester, Bath and Yeovil. Together with his ENT colleague Mr David Baldwin he leads the Bristol Acoustic Neuroma Service. Together they have operated on over 500 acoustic neuromas placing a special emphasis on minimising neurological complications and disability.
Miss Sue Garwood, Medical Secretary to Mr Richard Nelson
e-mail: susan.garwood@nbt.nhs.uk
Tel: 0117 4146702
Consultant Neurosurgeon and Head of Specialty (Neurosurgery)
Mr David Porter
Mr David Porter qualified in Medicine at the University of London Medical School in 1987. He subsequently worked for the Professor of Surgery. He pursued a General Surgical Training in Liverpool and was successful in passing the Fellowship to the Royal College of Surgeons in 1991. He immediately applied and was successfully appointed to Neurosurgical training in London and worked at the Centres of Charing Cross, The Royal Free and Queens Square Hospitals. Mr Porter then transferred to Leeds for his Senior Registrar post and during this time he spent time at the Barrow Neurological Institute, Phoenix, Arizona under the supervision of the Internationally renowned Surgeons Robert Spetzler and Volkar Sonntag. He returned to the United Kingdom to accept a post as Consultant Neurosurgeon at Frenchay Hospital and from this point he maintained a Neurosurgical Practice encompassing a broad base of conditions. In keeping with developing trends an interests he began to further sub-specialise into complex skull base tumours and cerebrovascular surgery. He is now a Tutor to the Royal College of Surgeons and he has an academic interest in the utilisation of high flow bypass for patients with a high risk of stroke and quality of life assessment for those patients undergoing skull base tumour resection. He is currently the Head of Department for Neurosurgery, Chair of the Site Specific Group for Neuro-oncology and Heads the Meningioma Service.
Medical Secretary: Rose Hembery
Tel: 0117 4146707
Email: rose.hembery@nbt.nhs.uk
Consultant Neuroradiologist
Dr Marcus Bradley BSc MBBS MRCP FRCR
Dr Marcus Bradley was appointed as a Consultant Neuroradiologist in 2008. He qualified in medicine from Imperial College School of Medicine, London in 1996 (St Mary’s Hospital Medical School) gaining a neuroscience BSc in 1993. He did his general medical training at the University Hospital Birmingham, before a period doing neurology research at University College London, based predominantly at the Royal Free Hospital. He undertook general radiology training in Bristol with sub-specialty training in diagnostic and interventional neuroradiology at Frenchay Hospital and an interventional fellowship in Ankara, Turkey. He is a Clinical Tutor for the Royal College or Radiologists and his interests include neurovascular disease and neuro-oncology.
e-mail: marcus.bradley@nbt.nhs.uk
Consultant Neuropathologist/Honorary Senior Lecturer
Dr Kathreena Kurian
Kathreena trained at Guy’s and St.Thomas’ Hospital Medical Schools, London, also gaining a BSc in Experimental Pathology. She specialised in Neuropathology in Edinburgh and Cambridge, during which time she won an Edinburgh Medical Faculty Research Fellowship which supported her research MD, achieved FRCPath (Neuro) and gained special paediatric neuropathology experience. She has recently spent time in Austin Smith’s Centre for Stem Cell Research in Cambridge and has many active research studies. She currently sits on the National Cancer Research Institute (NCRI) Brain Tumour Subgroup for Translational Studies.
Joanna McTiernan, Medical Secretary to Dr Kathreena Kurian
Email: joanna.mctiernan@nbt.nhs.uk
Consultant Clinical Oncologist, Bristol Haematology and Oncology Centre
Dr Chris Herbert MBBS, FRCR
Dr Chris Herbert qualified in medicine at Birmingham University in 2000. He trained in Clinical Oncology in Bristol and completed his oncology training as a clinical research fellow at the British Columbia Cancer Agency in Vancouver, Canada, where he specialised in stereotactic radiosurgery and the treatment of benign and malignant adult brain tumours. Appointed as consultant Clinical Oncologist in Bristol in 2011, he has an interest in technical radiotherapy, specialising in the treatment of adult brain tumours, including stereotactic radiosurgery, skin tumours and urological cancers. He has published work on stereotactic radiosurgery in international, peer reviewed journals.
His other area of interest is in the treatment of malignant melanoma particulary management of brain metastases, including administration of new state-of-the art chemotherapy agents.
Email: christopher.herbert@uhbristol.nhs.uk
Medical secretary: 0117 3422417
Consultant Clinical Oncologist, Bristol Haematology and Oncology Centre
Dr Alison Cameron
Dr Alison Cameron trained at Bristol University. Her Clinical Oncology training was in South Wales and Bristol, prior to becoming a consultant in Bristol. With a particular interest in technical radiotherapy, she specialises in Paediatric Radiotherapy, Neuro-oncology including intracranial stereotactic radiosurgery and Skin Cancers. Since 2009 she has been lead clinician at University Hospitals Bristol for Teenagers and Young Adults with Cancer, charged with setting up the service for this group of patients. In her spare time she is a long distance runner and conservation volunteer for the National Trust.
Consultant Clinical Oncologist
Dr Sean Elyan MB ChB, MD (Bristol) FRCP, FRCR
e-mail: sean.elyan@glos.nhs.uk
Dr. Elyan qualified in medicine from Bristol University and obtained further medical experience in the West Country. His Oncology training was at Cambridge, Manchester where he did a research degree through the Paterson Institute, and the Royal Marsden Hospital in London as a Senior Registrar. His main clinical interests are breast cancer, CNS malignancies, Upper GI cancer and lymphomas. He also has an interest in Medical Management and was appointed as the Trust’s Medical Director at the end of 2005. This role is undertaken 2 ½ days per week.
Carolyn, Medical Secretary to Dr Sean Elyan
Telephone: 0845 422 4017
Consultant Clinical Oncologist
Dr Sam Guglani MB BS, MRCP, FRCR
e-mail: sam.guglani@glos.nhs.uk
Dr. Sam Guglani qualified in Medicine at University College Hospital London Medical School in June 1995, also completing a BSc in Neuroscience there. He undertook training in general medical at Frenchay Hospital in Bristol and subsequently proceeded to specialist registrar training in Clinical Oncology in Bristol and Cheltenham, completing in 2005. Following this, he spent a year as a Clinical and Research fellow at the Peter MacCallum Cancer institute in Melbourne, Australia prior to taking up a substantive Consultant post in Cheltenham as a Clinical Oncologist in March 2006. His clinical duties are shared between Cheltenham General Hospital and Hereford County Hospital; he specialises in the treatment of patients with breast, lung and brain cancers. He also has an academic interest in clinical ethics and sits on the hospital Clinical Ethics Committee.
Tania, Medical Secretary to Dr Sam Guglani
Telephone: 0845 422 4032


